CN109856407A - A kind of canine distemper virus antibody fluorescence test strip and its preparation method and application - Google Patents

A kind of canine distemper virus antibody fluorescence test strip and its preparation method and application Download PDF

Info

Publication number
CN109856407A
CN109856407A CN201811596427.7A CN201811596427A CN109856407A CN 109856407 A CN109856407 A CN 109856407A CN 201811596427 A CN201811596427 A CN 201811596427A CN 109856407 A CN109856407 A CN 109856407A
Authority
CN
China
Prior art keywords
pad
canine distemper
coated
distemper virus
conjugate release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201811596427.7A
Other languages
Chinese (zh)
Other versions
CN109856407B (en
Inventor
何方洋
崔廷婷
王兆芹
龙光宗
鲁晓雄
刘二战
万宇平
贾芳芳
朱亮亮
冯才伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Kwinbon Biotechnology Co Ltd
Original Assignee
Beijing Kwinbon Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Kwinbon Biotechnology Co Ltd filed Critical Beijing Kwinbon Biotechnology Co Ltd
Priority to CN201811596427.7A priority Critical patent/CN109856407B/en
Publication of CN109856407A publication Critical patent/CN109856407A/en
Application granted granted Critical
Publication of CN109856407B publication Critical patent/CN109856407B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention discloses a kind of canine distemper virus antibody fluorescence test strips and its preparation method and application.Test strips provided by the present invention include sample absorption pad, conjugate release pad a, conjugate release pad b, nitrocellulose filter, water absorption pad and bottom plate, the anti-dog antiantibody-biotin conjugates of chicken are coated on the conjugate release pad a, Streptavidin-Fluorescent microsphere marker is coated on the conjugate release pad b, there are detection line and nature controlling line on the nitrocellulose filter, it is coated with canine distemper virus N expression albumen in the detection line, is coated with goat-anti chicken antiantibody on the nature controlling line.Test strips of the invention have many advantages, such as high sensitivity, high specificity, easy to operate, economical and practical, it can be achieved that canine distemper virus antibody scene rapid quantitative detection.

Description

A kind of canine distemper virus antibody fluorescence test strip and its preparation method and application
Technical field
The present invention relates to the detections of canine distemper virus antibody, and in particular to a kind of canine distemper virus antibody fluorescence Test paper Item and its preparation method and application.
Technical background
Canine distemper (Canine Distemper, CD) is by canine distemper virus (Canine Distemper Virus, CDV) A kind of acute, highly contagious disease caused by infection, is endangered to canine farming, fur animal farming and the conservation of wildlife One of maximum epidemic disease of evil.CDV belongs to Paramyxoviridae Morbillivirus, is the ameristic RNA virus of minus strand sub-thread.CDV master It will be by 6 hatching eggs such as nucleocapsid protein N, phosphoprotein P, matrix membrane protein M, fusion protein F, attachment or hemagluttinin proteins H, large protein L White composition, wherein nucleocapsid protein N, fusion protein F and hemagluttinin proteins H are the main purpose antigen of dog immune system, are to produce The important antigen of raw neutralizing antibody.Nucleocapsid protein N is the stronger immunogenic protein of conservative, removes epitope containing B cell, also contains There is t cell epitope, plays a major role in the early immune response of canine distemper infection, strong antibody response can be caused.
Canine distemper virus disease mainly passes through vaccine prevention, and knot will be generated in vaccine immunity animal and infection animal body Structure protein antibodies, therefore the diagnostic method of detection structure protein antibodies can determine that animal to the resistance of Strain.It is daily simultaneously It is that the daily monitoring to group selects vaccine, assessment immune programme reasonability, grasps health status that monitoring vaccine, which generates antibody, Important means, while can also reflect from side and manage main foundation that is whether reasonable, and vaccinating in due course.
The serological method for detecting CDV antibody established at present mainly have hemagglutination-inhibition test, neutralization test, ELISA method and Colloidal Gold etc..Hemagglutination-inhibition test needs fresh and high sensibility red blood cell, and detection time needs 2 ~3h;Neutralization test is cumbersome, needs higher experimental condition and operation horizontal, and entire test needs 1~2 week time could Result out;ELISA method high operation requirements needs microplate reader measurement result, and is not suitable for doing the detection of single sample;Immune glue Body gold method is although easy to detect, is not required to professional technician and working environment, but the sensitivity of its detection is low, and can only be qualitative, Detection range is narrow.These all limit their applications in the detection of canine distemper virus antibody clinical, therefore, the invention patent Purpose is exactly that it is anti-to establish a kind of canine distemper virus easy to operate, sensitive, special, quick the shortcomings that overcoming the above several method Body quantitative detecting method, applied to the monitoring of canine distemper virus immune effect, to limit the prevalence of canine distemper virus.
Summary of the invention
It is an object of the present invention to provide a kind of canine distemper virus antibody fluorescence test strips.
Canine distemper virus antibody fluorescence test strip provided by the present invention, including the release of sample absorption pad, conjugate Pad a, conjugate release pad b, nitrocellulose filter, water absorption pad and bottom plate;It is anti-that the anti-dog of chicken is coated on the conjugate release pad a Antibody-biotin conjugate;Streptavidin-Fluorescent microsphere marker is coated on the conjugate release pad b;The nitric acid There are detection line and nature controlling line on cellulose membrane, canine distemper virus N expression albumen is coated in the detection line, on the nature controlling line It is coated with goat-anti chicken antiantibody.
The anti-dog antiantibody of chicken used on the conjugate release pad a is the IgY of the anti-dog IgG of chicken, the nitrocellulose The goat-anti chicken antiantibody that nature controlling line uses on film is the IgG of goat-anti chicken IgY.
The sample absorption pad, conjugate release pad a, conjugate release pad b, nitrocellulose filter, water absorption pad are sequentially solid It is scheduled on the bottom plate.
It is a further object to provide a kind of preparation sides of above-mentioned canine distemper virus antibody fluorescence test strip Method comprising step:
1) Quality Control that preparation has the detection line for being coated with canine distemper virus N expression albumen and is coated with goat-anti chicken antiantibody The nitrocellulose filter of line;
2) preparation is coated with the conjugate release pad a of the anti-dog antiantibody-biotin conjugates of chicken and to be coated with strepto- affine Element-Fluorescent microsphere marker conjugate release pad b;
3) sample absorption pad, conjugate release pad a, conjugate release pad b, nitrocellulose filter, water absorption pad is sequentially solid It is scheduled on bottom plate.
Specifically, step includes:
1) expression and purifying of canine distemper virus N protein;
2) 1) the canine distemper virus N protein of expression is coated on composition detection line (T) on nitrocellulose filter, it will be commercially available Goat-anti chicken antiantibody is coated on composition nature controlling line (C) on nitrocellulose filter;
3) the anti-dog antiantibody-biotin conjugates of commercially available chicken are sprayed in conjugate release pad, after 37 DEG C of drying 2h It takes out, as conjugate release pad a is placed in dry environment and saves backup;
4) Streptavidin is added in the fluorescent microsphere solution activated, prepares Streptavidin-fluorescent microsphere mark Remember object;
5) Streptavidin-Fluorescent microsphere marker by 4) preparation is sprayed in conjugate release pad, 37 DEG C of drying 2h After take out, as conjugate release pad b is placed in dry environment and saves backup;
6) sample absorption pad is used to the 0.02mol/L phosphate-buffered containing 0.5% bovine serum albumin(BSA) (BSA), pH 7.2 Liquid impregnates 2h, and 37 DEG C of drying 2h are spare;
7) sample absorption pad, conjugate release pad a, conjugate release pad b, nitrocellulose filter, water absorption pad are successively pressed Sequence is pasted on bottom plate, and the small item of 3.95mm wide is cut into machine, close with aluminium foil bag in special plastics fabrication shell It seals, can be reserved for 12 months under the conditions of 2~30 DEG C.
Application of the above-mentioned canine distemper virus antibody fluorescence test strip in detection canine distemper virus antibody is also this hair The range of bright protection.
Canine distemper virus antibody fluorescence test strip of the invention is reacted and is exempted from using the antibody antigen of high degree of specificity Epidemic disease Chromatographic techniques fix the anti-dog antiantibody-biotin conjugates of chicken and Streptavidin-Fluorescent microsphere marker respectively In in two conjugate release pads, the canine distemper virus antibody in sample is in flow process, first and on conjugate release pad a The anti-dog antiantibody of chicken-biotin conjugates combine, then by biotin-Streptavidin system and conjugate release pad b Streptavidin-Fluorescent microsphere marker combines, and forms antibody-antiantibody-fluorescent microsphere compound.Antibody in sample is by nitre Canine distemper virus N expression albumen capture in acid cellulose film detection line, by fluorescent chromatographic analyzer quantitative detection sample Canine distemper virus antibody titer.
Test strips of the invention have that high sensitivity, high specificity, at low cost, easy to operate, detection time is short, it is each to be suitble to The advantages of kind unit uses, storage is simple, long shelf-life.Wherein, fluorescent microsphere label is effectively reduced on Streptavidin Issuable steric hindrance, improves the joint efficiency of Ag-Ab when mark fluorescent microballoon, to improving detection sensitivity There is larger help;And by the multi-level amplification of biotin-Streptavidin system, while improving sensitivity, Do not increase nonspecific interference, can also reduce operating error, improves the accuracy of measurement.Test strips of the present invention can realize hundstaupe Fever virus antibody field quick detection, practical value and promotional value with higher.
Detailed description of the invention
Fig. 1 is test strips the schematic diagram of the section structure.
Fig. 2 is canine distemper virus antibody test canonical plotting.
Specific embodiment
Below with reference to specific embodiment, the present invention is further explained.It should be understood that these embodiments are merely to illustrate this Invention, and be not intended to limit the scope of the invention.In addition, the range that those skilled in the art limits in the appended claims Interior to carry out various changes or modification to the present invention, these changes or modification should equally fall into protection scope of the present invention.
Embodiment 1: the composition (Fig. 1) of canine distemper virus antibody fluorescence test strip
The test strips are by bottom plate (8), sample absorption pad (1), conjugate release pad a (2), conjugate release pad b (3), nitrocellulose filter (4), water absorption pad (5) composition;
The sample absorption pad (1), conjugate release pad a (2), conjugate release pad b (3), nitrocellulose filter (4), Water absorption pad (5) is successively pasted onto order on PS bottom plate (8);Conjugate release pad a (2) has 1/4 region by sample from starting point Absorption pad (1) covering, conjugate release pad b (3) have 1/4 region to be combined object release pad a (2) covering, conjugate from starting point The end of release pad b (3) is connect with the beginning of nitrocellulose filter (4), the end and water absorption pad (5) of nitrocellulose filter (4) Beginning be connected, the beginning of sample absorption pad (1) is aligned with the beginning of PS bottom plate (8), the end of water absorption pad (5) and PS bottom plate (8) end alignment;
There are detection line (6) and nature controlling line (7) on the nitrocellulose filter (4), detection line (T) and nature controlling line (C) are in The perpendicular strip tape with the length of the test strips;Detection line (6) is located at the side close to the end of conjugate release pad b (3); Nature controlling line (7) is located remotely from the side of the end of conjugate release pad b (3).Test strips are cut into the small of 3.95mm wide with machine Item is sealed in special plastics fabrication shell with aluminium foil bag, can be reserved for 12 months under the conditions of 2~30 DEG C.
Embodiment 2: the preparation of test strips described in embodiment 1
The preparation method of the test strips mainly comprises the steps that
1) Quality Control that preparation has the detection line for being coated with canine distemper virus N expression albumen and is coated with goat-anti chicken antiantibody The nitrocellulose filter of line;
2) preparation is coated with the conjugate release pad a of the anti-dog antiantibody-biotin conjugates of chicken and to be coated with strepto- affine Element-Fluorescent microsphere marker conjugate release pad b;
3) sample absorption pad, conjugate release pad a, conjugate release pad b, nitrocellulose filter, water absorption pad is sequentially solid It is scheduled on bottom plate.
Substep narration in detail below:
(1) preparation of each component
1. the expression and purifying of canine distemper virus N protein
(1) sequence information
1. CDV-N 275-523 gene order: tttggcattgaaactatgtatccggctcttgggttgcatgagtt ttccggagagttaacaactattgaatcccttatgatgctatatcaacagatgggtgaaacagcaccgtacatggtt attctggaaaattctgttcagaacaaatttagtgcaggatcctacccactgctctggagttatgctatgggagttg gtgttgaacttgaaaactccatgggagggttaaatttcggtagatcctactttgatccggcctatttcaggctcgg gcaagaaatggtgagaagatctgccggcaaagtaagctctgcacttgccgccgagcttggcatcaccaaggaagag gctcagctagtgtcagaaatagcatccaagacaacggaggaccggacgattcgcactgctggtcccaagcaatctc aaatcacttttctgcactcagaaagatccgaagtcactaatcaacaacccccaaccatcaacaagaggtccgaaaa ccaaggaggagacaaataccccatccacttcaatgatgaacggtttccagggtacacccctgatgtcaacagctcc gaatggagtgaatcacgctatgatacccagactattcaagatgatggaaacgacgatgaccggaaatcgatggaag caatcgccaagatgagaatgcttactaagatgctcagtcaacctgggaccagtgaagagagttctcctgtctataa tgatagagagctactcaat
2. amino acid sequence: PLGSPEFFGIETMYPALGLHEFSGELTTIESLMMLYQQMGETAPYMVILENSVQN KFSAGSYPLLWSYAMGVGVELENSMGGLNFGRSYFDPAYFRLGQEMVRRSAGKVSSALAAELGITKEEAQLVSEIAS KTTEDRTIRTAGPKQSQITFLHSERSEVTNQQPPTINKRSENQGGDKYPIHFNDERFPGYTPDVNSSEWSESRYDTQ TIQDDGNDDDRKSMEAIAKMRMLTKMLSQPGTSEESSPVYNDRELLN
(2) gene chemical synthesis and vector construction
According to Gene Bank (Sequence ID:JN896331) sequence, the 275-523 amino acids sequence of N protein is synthesized Column, and construct by restriction enzyme site of Nde1 and Xho1 into PET-28A plasmid.
(3) plasmid is converted into BL21 (DE3) competent cell
1. 2 μ L of plasmid is added in 100 μ L competent bacterias, 30min on ice is set.
2. 42 DEG C of heat shock 90s, set rapidly 5min in ice;500 μ L LB culture solutions are added.
3. 37 DEG C, 220r/min shaking 1h, are all coated on the LB plate of that resistance containing card after centrifugation, 37 DEG C of inversions trainings It supports overnight.
(4) expression identification
1. monoclonal is inoculated in the test tube of 4mL LB culture solution of that resistance containing card on 11 plates of picking.
2. 37 DEG C, 220r/min shakes to thallus OD600It is 0.6~0.8.
3. taking out 1mL culture, 12000g room temperature is centrifuged 5min, abandons supernatant, and thallus is resuspended with 80 μ 1 × PBS buffer solution of L Precipitate and be added 5 × Loading Buffer of 20 μ L.
4. IPTG to final concentration of 0.5mmol/L is added into remaining culture, 4h is shaken in 37 DEG C, 220r/min, Induced fusion protein expression.
5. taking out 0.5mL culture, 12000g room temperature is centrifuged 5min, abandons supernatant, and bacterium is resuspended with 80 μ 1 × PBS buffer solution of L Body precipitates and 5 × Loading Buffer of 20 μ L is added.
6. carrying out 12%SDS-PAGE analysis, expressing fusion protein is obvious.
(5) amplification expression and affinity purification
1. take optimal clone conservation bacterium to be seeded in the LB culture medium of 1L that resistance containing card, 37 DEG C, 220r/min shake to OD600=0.6~0.8, after final concentration of 0.1mmol/L IPTG is added, 37 DEG C, 220r/min shaking 4h.
2. 8000r/min is centrifuged 15min, discards supernatant, collect all thallus.
3. using Buffer A (20mmol/L Imidazole, 20mmol/L Tris, 500mmol/L NaCl, pH8.0) Thallus, ultrasonication (Φ 10,20%, 3s/4s, 30min) is resuspended, 8000r/min is centrifuged 15min, collects supernatant.
4. remove supernatant, inclusion body protein with Buffer B (20mmol/L Imidazole, 20mmol/L Tris, 500mmol/L NaCl, 8mol/L Urea, pH 8.0) soluble protein.
5. crossing column using the Buffer A of 40mL or so after activating nickel column.
6. inclusion body protein crosses 3 nickel columns repeatedly.
7. crossing column with the Buffer B of 20mL or so, foreign protein is washed away.
8. utilizing Buffer C (250mmol/L Imidazole, 20mmol/L Tris, 500mmol/L NaCl, 8mol/ L Urea, pH 8.0) elution, collect eluent.
9. SDS-PAGE electrophoresis detection.
(6) protein renaturation dialysis after purification
1. the sample cell after purification containing albumen is merged into two dialysis bands.
2. gradient dialysis renaturation, 8mol/L Urea-4mol/L Urea-2mol/L Urea-0.2mol/L PBS, every rank Section dialysis 3h.
3. 5% or so glycerol are added, -20 DEG C of preservations.
2. the preparation of Streptavidin-Fluorescent microsphere marker
(1) activation of fluorescent microsphere
1% fluorescent microsphere of 4 DEG C of placements is taken, restores room temperature, takes 50 μ L to set in PE pipe with pipettor after shaking up, 450 μ are added L ultrapure water carries out 10 times of dilutions (0.1%, volume fraction), this is working solution;Activator EDC, NHS are weighed, with selected ratio point Oscillation Jia Ru not be protected from light in working solution, react 15min;15000r/min is centrifuged 10min;It discards supernatant, takes 500 μ L PBS multiple It is molten, it shakes up.
MES solution is prepared: it weighs 1.82g MES and is dissolved in 90mL ultrapure water, required pH is adjusted to 2mol/L NaOH, It is settled to 100mL, packing freezes, and room temperature is returned back to before use.
Activator EDC is prepared: being weighed 10mg EDC, is drawn the MES solution 1mL dissolution of above-mentioned preparation, make final concentration of 10mg/mL is protected from light, ready-to-use.
Activator NHS is prepared: being weighed 10mg NHS, is drawn the MES solution 1mL dissolution of above-mentioned preparation, make final concentration of 10mg/mL is protected from light, ready-to-use.
(2) Streptavidin-Fluorescent microsphere marker preparation
Streptavidin is diluted to 1mg/mL with PBS, 20 μ L of addition are interior to the fluorescent microsphere (500 μ L) activated, mix It is even, it is protected from light oscillation, marks 4h;15000r/min is centrifuged 10min, discards supernatant.
(3) Streptavidin-Fluorescent microsphere marker closing
It takes 500 μ L confining liquids to redissolve marked good fluorescent microsphere, is protected from light oscillation, close 1h;15000r/min centrifugation 10min is discarded supernatant.
Confining liquid: the 0.02mol/L phosphate buffer containing 5%BSA (mass fraction), pH 7.2.
(4) Streptavidin-Fluorescent microsphere marker redissolution
It takes 500 μ L to redissolve liquid to redissolve the Streptavidin closed-Fluorescent microsphere marker, mixes 4 DEG C of ice of postposition Case is spare.
Redissolve liquid: the 0.02mol/L phosphate buffer containing 0.5%BSA (mass fraction), pH 7.2.
3. the preparation of conjugate release pad
Conjugate release pad is soaked in the 0.02mol/L phosphate-buffered containing 0.3%Cas (mass fraction), pH 7.4 In liquid, 2h is uniformly soaked, 37 DEG C are dried for standby.Film instrument is drawn by the anti-dog antiantibody-biotin conjugates of commercially available chicken with Bio dot (conjugate release pad a), it is anti-that every 1cm conjugate release pad sprays the 0.7 anti-dog of μ L chicken to even application in conjugate release pad Body-biotin conjugates is subsequently placed in 37 DEG C of environment (humidity < 20%) and takes out after 2h, is placed in dry environment (humidity < 20%) it is saved backup in.
Film instrument is drawn with Bio dot to release the Streptavidin prepared-Fluorescent microsphere marker even application in conjugate Putting pad, above (conjugate release pad b), every 1cm conjugate release pad spray 0.5 μ L Streptavidin-Fluorescent microsphere marker, so It is placed in 37 DEG C of environment (humidity < 20%) and is taken out after 2h, be placed in dry environment (humidity < 20%) and save backup.
4. the preparation of nitrocellulose filter
The canine distemper virus N protein of expression is coated on nitrocellulose filter and constitutes detection line, by goat-anti chicken antiantibody It is coated on nitrocellulose filter and constitutes nature controlling line.
Coating process: the canine distemper virus N protein of expression is diluted to 500 μ g/mL with phosphate buffer, with Bio dot It draws film instrument and is coated in the detection line (T) on nitrocellulose filter, package amount is 1.0 μ L/cm;With 0.01mol/L, pH 7.2 Phosphate buffer goat-anti chicken antiantibody is diluted to 300 μ g/mL, with Bio dot draw film instrument be coated in cellulose nitrate Nature controlling line (C) on plain film, package amount are 1.0 μ L/cm.It is dry under the conditions of the nitrocellulose filter being coated with is placed in 37 DEG C 16h, it is spare.
5. the preparation of sample absorption pad
0.02mol/L phosphate buffer of the sample absorption pad containing 0.5%BSA, pH 7.2 is impregnated into 2h, 37 DEG C of drying 2h is spare.
(2) assembling of each component
Sample absorption pad, conjugate release pad a, conjugate release pad b, nitrocellulose filter, water absorption pad are successively pressed suitable Sequence is pasted on PS bottom plate;Conjugate release pad a has 1/4 region to be absorbed by the sample pad covering, conjugate release pad b from starting point There is 1/4 region to be combined object release pad a covering, the end of conjugate release pad b and the beginning of nitrocellulose filter from starting point Connection, the end of nitrocellulose filter are connected with the beginning of water absorption pad, and the beginning of sample absorption pad is aligned with the beginning of PS bottom plate, The end of water absorption pad is aligned with the end of PS bottom plate;Have detection line (T) and nature controlling line (C) on nitrocellulose filter, detection line and Nature controlling line is in the strip tape perpendicular with the length of the test strips;Detection line is located at close to the end of conjugate release pad b Side;Nature controlling line is located remotely from the side of the end of conjugate release pad b.Test strips are cut into the small of 3.95mm wide with machine Item is sealed in special plastics fabrication shell with aluminium foil bag, can be reserved for 12 months under the conditions of 2~30 DEG C.
Embodiment 3: the use of test strips described in embodiment 1
1. the preparation of sample
(1) plasma sample: with anticoagulant blood sampling tube, or being first added EDTA anti-coagulants in heparin tube, and acquisition blood is added And slowly shake up, 3000~5000r/min room temperature is centrifuged 10~30min (adjusting in right amount according to blood sampling volume).It is clear to draw upper layer yellow Bright liquid is plasma sample.
(2) serum sample: acquisition blood is added in heparin tube and (is free of anti-coagulants), room temperature slant setting has to upper layer 3000~5000r/min room temperature centrifugation 10~30min (being adjusted in right amount according to blood sampling volume) when clear yellow liquid is precipitated.Draw upper layer Clear yellow liquid is serum sample.
(3) Sample Dilution: taking the above-mentioned sample restored to room temperature, 5 μ L is accurately drawn with pipettor, Sample Dilution is added It manages in (the 0.02mol/L phosphate buffer containing 1000 μ L pH 7.2), mixes well, this is prepare liquid, it is disposed vertically, to It surveys.
2. test strips detect
It draws 70 μ L of prepare liquid with pipettor vertically to drip in well, liquid flowing starts timing, reacts 10min, adds Outside, by the detection hole of test strips insertion fluorescent chromatographic analyzer, Pen-down detection key will automatically carry out test strips sample nose end Interpretation.If not occurring C line, shows that incorrect operating process or test strips have been failed, retested using new test strips.
3. testing result interpretation
Canine distemper virus antibody standard substance is configured to series of concentrations with Sample dilution: 0,1/1024,1/256,1/64, 1/16,1/4, it takes 70 μ L to be added drop-wise in the well of test strips, detection line and matter is read by fluorescent chromatographic analyzer after 10min The ratio of line signal strength, i.e. T/C value (each concentration point measures 4 times respectively, is averaged) are controlled, corresponding standard curve is drawn (Fig. 2).
Using above-mentioned standard curve detection clinical sample, by the standard curve Y=(a-d) of drafting/[1+ (x/c)b] in+d A, b, c, d value input fluorescent chromatographic analyzer can immediately arrive at canine distemper virus in actual sample when measuring actual sample The titre of antibody.
As a result it explains:
Testing result Clinical application reference
<1 Antibody level is extremely low, such as animal health, it is proposed that vaccine inoculation immediately
1~3 Antibody level is lower, such as animal health, it is proposed that in due course vaccine inoculation
3~4 Antibody level is moderate, and animal is centainly protected, it is proposed that periodic monitoring antibody level
4~5 Antibody level is higher, and animal is centainly protected, and the wild poison of contact should be avoided
5~6 Antibody level is high, and animal is protected, and the wild poison of contact should be avoided
>6 Antibody level is very high, and animal has the wild malicious risk of contact in the recent period, needs close observation
Embodiment 4: the evaluation of test strips described in embodiment 1
1. precision measures
Canine distemper virus antibody standard substance is configured to series of concentrations with Sample dilution: 1/1024,1/64,1/4, respectively (each concentration every batch of detects 24 parallel, detections three batches altogether respectively) is detected with test strips.
Crowd interior maximum CVs of each concentration is 9.3%, and average CVs is 7.2%;Each concentration batch between maximum CVs be 10.3%, average CVs is 8.5%, shows that test strips provided by the present invention have good repeatability.
2. Stability Determination
By the test strips prepared be placed on 4 DEG C, 25 DEG C, 37 DEG C, carry out accelerated test in 45 DEG C of environment.Respectively 7d, 14d, 21d and 28d take out, and the titre of canine distemper virus antibody in actual sample is detected with it.To measured concentration and practical sample Product concentration values carry out error analysis, obtain CV value within 10% as a result, showing that test strips provided by the present invention have Good stability.
3. relativity determination
Comb enzyme using test strips of the invention and control ICL International Computer Limited exempts from kit, simultaneously to 64 parts of dog serum samples It is measured, correlation analysis is carried out to measured value, the results show that the related coefficient of two methods is R2=0.932, show this The test strips of invention and the correlation of import reagent measurement result are good, have specificity and accuracy well.

Claims (5)

1. a kind of canine distemper virus antibody fluorescence test strip, including sample absorption pad, conjugate release pad a, conjugate are released Put pad b, nitrocellulose filter, water absorption pad and bottom plate, it is characterised in that: it is anti-that the anti-dog of chicken is coated on the conjugate release pad a Antibody-biotin conjugate;Streptavidin-Fluorescent microsphere marker is coated on the conjugate release pad b;The nitric acid There are detection line and nature controlling line on cellulose membrane, canine distemper virus N expression albumen is coated in the detection line, on the nature controlling line It is coated with goat-anti chicken antiantibody.
2. canine distemper virus antibody fluorescence test strip according to claim 1, it is characterised in that: the conjugate is released The anti-dog antiantibody of chicken used on pad a is put as the IgY of the anti-dog IgG of chicken, the goat-anti that nature controlling line uses on the nitrocellulose filter Chicken antiantibody is the IgG of goat-anti chicken IgY.
3. canine distemper virus antibody fluorescence test strip according to claim 1 to 2, it is characterised in that: the sample Product absorption pad, conjugate release pad a, conjugate release pad b, nitrocellulose filter, water absorption pad are sequentially fixed on the bottom plate.
4. a kind of preparation method of any canine distemper virus antibody fluorescence test strip of claim 1-3, feature It is: includes the following steps:
1) preparation is with the detection line and the nature controlling line for being coated with goat-anti chicken antiantibody for being coated with canine distemper virus N expression albumen Nitrocellulose filter;
2) preparation is coated with the conjugate release pad a of the anti-dog antiantibody-biotin conjugates of chicken and to be coated with Streptavidin-glimmering The conjugate release pad b of light microballoon marker;
3) sample absorption pad, conjugate release pad a, conjugate release pad b, nitrocellulose filter, water absorption pad are sequentially fixed on On bottom plate.
5. any canine distemper virus antibody fluorescence test strip of claim 1-3 is in detection canine distemper virus antibody Application.
CN201811596427.7A 2018-12-26 2018-12-26 Canine distemper virus antibody fluorescence detection test strip and preparation method and application thereof Active CN109856407B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811596427.7A CN109856407B (en) 2018-12-26 2018-12-26 Canine distemper virus antibody fluorescence detection test strip and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811596427.7A CN109856407B (en) 2018-12-26 2018-12-26 Canine distemper virus antibody fluorescence detection test strip and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN109856407A true CN109856407A (en) 2019-06-07
CN109856407B CN109856407B (en) 2022-11-18

Family

ID=66892306

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811596427.7A Active CN109856407B (en) 2018-12-26 2018-12-26 Canine distemper virus antibody fluorescence detection test strip and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN109856407B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109628490A (en) * 2019-01-26 2019-04-16 青岛农业大学 A kind of shRNA recombinant adeno-associated virus preventing canine distemper
CN110699493A (en) * 2019-12-04 2020-01-17 军事科学院军事医学研究院军事兽医研究所 Primer, probe and kit for detecting panda canine distemper virus
CN112946252A (en) * 2021-02-01 2021-06-11 福州海关技术中心 Fluorescent test strip for identifying duck meat doped in beef and mutton and preparation method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102103145A (en) * 2011-02-24 2011-06-22 南京基蛋生物科技有限公司 Colloidal gold test strip for double-amplification system and preparation method thereof
CN104280549A (en) * 2014-09-16 2015-01-14 中山生物工程有限公司 EB virus VCA-IgA antibody detection reagent and preparation method thereof
CN105181960A (en) * 2015-10-15 2015-12-23 厦门宝太生物科技有限公司 Fluorescent immunochromatography test paper and preparation method thereof
CN204964520U (en) * 2015-09-10 2016-01-13 刘雄 A detect card for short -term test antiviral antibody
CN106248974A (en) * 2016-07-11 2016-12-21 武汉百美生物科技有限公司 A kind of hypersensitivity immunity chromatography detection test paper

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102103145A (en) * 2011-02-24 2011-06-22 南京基蛋生物科技有限公司 Colloidal gold test strip for double-amplification system and preparation method thereof
CN104280549A (en) * 2014-09-16 2015-01-14 中山生物工程有限公司 EB virus VCA-IgA antibody detection reagent and preparation method thereof
CN204964520U (en) * 2015-09-10 2016-01-13 刘雄 A detect card for short -term test antiviral antibody
CN105181960A (en) * 2015-10-15 2015-12-23 厦门宝太生物科技有限公司 Fluorescent immunochromatography test paper and preparation method thereof
CN106248974A (en) * 2016-07-11 2016-12-21 武汉百美生物科技有限公司 A kind of hypersensitivity immunity chromatography detection test paper

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109628490A (en) * 2019-01-26 2019-04-16 青岛农业大学 A kind of shRNA recombinant adeno-associated virus preventing canine distemper
CN110699493A (en) * 2019-12-04 2020-01-17 军事科学院军事医学研究院军事兽医研究所 Primer, probe and kit for detecting panda canine distemper virus
CN112946252A (en) * 2021-02-01 2021-06-11 福州海关技术中心 Fluorescent test strip for identifying duck meat doped in beef and mutton and preparation method and application thereof

Also Published As

Publication number Publication date
CN109856407B (en) 2022-11-18

Similar Documents

Publication Publication Date Title
CN109765384A (en) A kind of canine coronavirus antibody fluorescence test strip and its preparation method and application
CN109765383A (en) A kind of feline distemper virus antibody fluorescence test strip and its preparation method and application
CN109856406A (en) A kind of canine parvovirus antibody fluorescence test strip and its preparation method and application
CN108398562A (en) Cystatin C fluorescent micro-ball immune chromatography quantitative testing test paper item and test card
CN109856407A (en) A kind of canine distemper virus antibody fluorescence test strip and its preparation method and application
CN107167597A (en) Quantitatively detection SAA, CRP, PCT immunofluorescence chromatographs kit and preparation method thereof
CN106153927A (en) A kind of fast quantification detects time-resolved fluoroimmunoassay chromatography reagent and the preparation method of cTnI, CKMB, Myo simultaneously
CN101000343A (en) Immunological test element with improved control zone
CN108333357A (en) A kind of magnetic bead time-resolved fluoroimmunoassay quantitatively detects CK-MB kits
CN109406778A (en) The time-resolved fluorescence quantitative test paper item and its preparation method and application of ralstonia solanacearum in a kind of detection tobacco leaf
CN101561437A (en) Immunity bead chromatograph test strip for quick testing ractopamine and preparation method thereof
CN108802407A (en) A kind of test strips and its preparation method and application method of detection morphine
CN101551390A (en) Immuomagnetic bead chromatographic test strip for rapidly detecting algae toxin and preparation method thereof
CN108802393A (en) A kind of test strips and its preparation method and application method of detection tetrahydro-cannabinolic acid
CN108845151A (en) A kind of test strips and its preparation method and application method detecting crystal methamphetamine
CN108982882A (en) A kind of digital information vitamin D rapid detection system and method
CN108956974A (en) A kind of test strips and its preparation method and application method detecting ketamine
CN101315379B (en) Reagent kit for detecting Ractopamine and application thereof
CN113514636A (en) New crown neutralizing antibody fluorescence immunochromatographic assay test strip and preparation method thereof
CN101666800B (en) Fast test strip of vesicular stomatitis virus (VSV) and preparation method thereof
CN101285839A (en) Quick detection method for newcastle disease virus and its immune colloidal gold test card
CN106932592B (en) Detect the colloidal gold strip and its preparation method and application of people&#39;s surfactant protein A
CN101551391A (en) Immuomagnetic bead chromatographic test strip for rapidly detecting chloromycetin and preparation method thereof
CN109406784A (en) A kind of detection microcapsule phycotoxin MC-LR time-resolved fluoroimmunoassay quantifies POCT test strips
CN110927380A (en) Duplex test strip for detecting methamphetamine and ketamine as well as preparation method and application method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant